New Delhi: Redcliffe Labs, a Pan India omnichannel diagnostics service provider, secures a coveted position in the esteemed Deloitte Technology Fast 50 India 2023, a testament to its rapid growth as a leading omnichannel diagnostics provider. This recognition reflects Redcliffe Labs’ dedication to making high-quality diagnostics accessible, affordable, and convenient nationwide for a Healthier Bharat.
- Redcliffe Labs secures a prominent position in the prestigious 18th Edition of Deloitte Technology Fast 50 India 2023, showcasing its commitment to pioneering accessible and innovative diagnostic solutions.
- This recognition underscores the company’s success in seamlessly integrating advanced technology, cost-efficiency, and convenience in healthcare diagnostics.
In a relatively short duration, Redcliffe Labs has rapidly expanded its extensive network, boasting 80+ state-of-the-art labs and 2000+ collection centres across 220+ cities in India. Leveraging innovative diagnostic solutions, the company ensures unparalleled services and patient experiences with home sample collection, maintaining the highest quality standards in Bharat, including Tier 2 & Tier 3 cities. With over 100% revenue growth in the past two years, Redcliffe Labs continues its commitment to advancing healthcare accessibility and quality.
Dheeraj Jain, Founder of Redcliffe Labs, said, “At Redcliffe Labs, we’re at the forefront of leveraging innovation and technology to redefine healthcare accessibility. Our commitment to affordable, accessible, and convenient diagnostics has driven our exceptional growth. Being recognized in the Deloitte Technology Fast 5 not only reflects financial success but also validates our dedication to enhancing healthcare outcomes in Indian communities. As one of the top five fastest-growing technology companies, we are honoured. Our focus on staying ahead in technology and innovation ensures improved customer experiences, supports clinicians, and contributes significantly to the industry’s advancement.”
Securing a position among the top five companies in the Deloitte Technology Fast 50 India ranking underscores Redcliffe Labs’ unwavering commitment to technology. Through its impactful contributions to the healthcare industry, Redcliffe Labs has demonstrated visionary leadership, determination, and adaptability in a rapidly evolving landscape,” commented Peeyush Vaish, Partner and TMT Industry Leader, Deloitte Touche Tohmatsu India LLP.
The Deloitte India Tech Fast 50 Programme, launched in 2005, honours the most innovative and fastest-growing public and private companies from all over India. The awards programme was created to recognize the passion and dedication it takes to be an industry disrupter using technology. Rankings are based on percentage revenue growth over three years. Redcliffe Lab’s inclusion among the top five companies underpins its growth, innovation, and impact in the healthcare diagnostic sector.
About Deloitte Technology Fast 50 India programme selection and qualifications:
The Deloitte Technology Fast 50 India programme, which was launched in 2005, is conducted by Deloitte Touche Tohmatsu India LLP (DTI LLP) and is part of a truly integrated Asia Pacific programme recognising India’s fastest growing and most dynamic technology businesses (public and private) and includes all areas of technology – from internet to biotechnology, from medical and scientific to computers/hardware.
The programme recognises the fastest-growing technology companies in India based on their percentage revenue growth over the past three financial years.
About Redcliffe Labs:
Redcliffe Labs is one of the fastest-growing omnichannel diagnostics service providers in India, which helps patients receive conclusive diagnoses with precision and accuracy. Redcliffe Labs services are available in 220+ cities across India through its wide network of owned advanced 80+ labs and 2000+ collection centres powered by home collection services, majorly targeting their future expansion in tier 2 and 3 masses. The company has served more than 4M+ patients with its high-end diagnostics services.
